Commercial Int Bank - Separate- Q12025

Commercial International Bank Egypt CIB

13/05/2025 07:00

RNS Number : 4195I

Commercial Intnl Bank (Egypt) SAE

13 May 2025

 

Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/4195I_1-2025-5-13.pdf

Commercial International Bank (Egypt) S.A.E.
Separate Financial Statements
March 31, 2025




0
Notes
Mar. 31, 2025
Dec. 31, 2024
Assets
Cash and balances at the central bank
9
67,709,656
136,165,920
Due from banks
10
314,144,761
270,089,441
Loans and advances to banks, net
12
16,109,873
9,555,410
Loans and advances to customers, net
13
361,830,507
340,955,698
Derivative financial instruments
930,893
819,711
Financial investments
- Financial Assets at Fair Value through OCI
14
259,396,282
233,029,903
- Financial Assets at Amortized cost
14
188,018,472
167,276,956
Investments in subsidiaries and associates
15
853,165
871,525
Non-current assets held for sale
28
159,828
159,828
Other assets
16
40,366,933
44,175,232
Deferred tax assets
2,536,325
2,337,304
Property and equipment
17
4,597,989
3,881,620
Total assets
1,256,654,684
1,209,318,548
Liabilities and equity
Liabilities
Due to banks
18
4,051,736
2,317,715
Due to customers
19
996,119,565
967,895,387
Derivative financial instruments
78,314
100,571
Current income tax liabilities
5,565,862
18,327,968
Other liabilities
20
45,946,585
21,347,499
Issued debt instruments
21
5,044,951
5,067,781
Other loans
23,948,624
23,962,389
Other provisions
22
19,032,774
18,613,060
Total liabilities
1,099,788,411
1,057,632,370
Equity
Issued and paid capital
30,431,580
30,431,580
Reserves
87,850,844
63,125,912
Reserve for employee stock ownership plan (ESOP)
2,184,420
1,868,235
Retained earnings*
36,399,429
56,260,451
Total equity and net profit for the period / year
156,866,273
151,686,178
Total liabilities and equity
1,256,654,684
1,209,318,548
##
The accompanying notes are an integral part of these financial statements.
(Review report attached)
*Including net profit for the period
Islam Zekry
Hisham Ezz Al-Arab
Group CFO & Executive Board Member
CEO & Executive Board Member
Condensed Separate Interim Income Statement for the period ended March 31, 2025
Last 9 Months
Last 9 Months
Notes
Mar. 31, 2025
Mar. 31, 2024
Interest and similar income
52,299,641
36,544,341
Interest and similar expense
(27,003,143)
(17,784,185)
Net interest income
25,296,498
18,760,156
Fee and commission income
3,510,324
2,684,283
Fee and commission expense
(1,586,144)
(1,118,950)
Net fee and commission income
1,924,180
1,565,333
Dividend income
12,751
610
Net trading income
6
641,395
16,202,679
Profits (Losses) on financial investments
14.1
376,684
224,271
Administrative expenses
(3,748,977)
(2,840,462)
Other operating income (expenses)
7
(1,735,421)
(14,923,188)
Impairment release (charges) for credit losses
(68,528)
(1,482,187)
Profit before income tax
22,698,582
17,507,212
Income tax expense
26
(6,514,216)
(5,722,492)
Deferred tax assets (Liabilities)
26
411,246
161,877
Net profit for the period
16,595,612
11,946,597
Earnings per share
8
Basic
4.83
3.47
Diluted
4.79
3.45
0
Islam Zekry
Hisham Ezz Al-Arab
Group CFO & Executive Board Member
CEO & Executive Board Member
Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2025
Last 9 Months
Last 9 Months
Mar. 31, 2025
Mar. 31, 2024
Net profit for the period
16,595,612
11,946,597
Net change on financial assets at fair value through comprehensive income after tax
2,141,325
1,977,715
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income
841,407
745,406
Total comprehensive income for the period
19,578,344
14,669,718
Condensed Separate Interim Cash Flows for the period ended March 31, 2025
Notes
Mar. 31, 2025
Mar. 31, 2024
Cash flow from operating activities
Profit before income tax
22,698,582
17,507,212
Adjustments to reconcile profits to net cash provided by operating activities
Fixed assets depreciation
17
353,476
261,427
Impairment release/charge for credit losses (Loans and advances to customers and banks)
(1,099,420)
1,772,387
Other provisions release/charge
22
317,074
40,759
Impairment release/charge for credit losses (due from banks)
144,661
(53)
Impairment release/charge for credit losses (financial investments)
1,023,287
(290,147)
Impairment release/charge for other assets
-
(4,782)
Exchange revaluation differences for financial assets at fair value through OCI and AC
212,785
(17,328,576)
Revaluation differences impairment charge for Financial Assets at Fair value through OCI
(13,337)
1,130,412
Revaluation differences impairment charge for Financial Assets at Amortized cost
1,240
95,225
Revaluation differences impairment charge for due from banks
-
101
Net utilized / recovered of other provisions
22
(520)
(4,517)
Exchange revaluation differences of other provisions
22
103,160
3,574,794
Profits/losses from selling property and equipment
(6,006)
-
Profits/losses from selling financial investments at fair value through OCI
14.1
(195,124)
(224,271)
Profits/losses from selling investments in associates
14.1
(181,560)
-
Share based payments
316,185
300,000
Operating profits before changes in operating assets and liabilities
23,674,483
6,829,971
Net decrease / increase in assets and liabilities
Due from banks
121,695,741
42,289,034
Financial assets at fair value through P&L
-
(974,297)
Derivative financial instruments
(142,036)
154,638
Loans and advances to banks and customers
(26,329,852)
(36,747,889)
Other assets
6,045,337
(5,850,432)
Due to banks
18
1,734,021
(6,855,319)
Due to customers
19
28,224,178
117,099,122
Current income tax obligations paid
(948,354)
(276,723)
Other liabilities
5,716,835
1,851,912
Net cash generated from (used in) operating activities
159,670,353
117,520,017
Cash flow from investing activities
Proceeds from sale of investments in associates
226,698
4,782
Payments for investment in subsidiaries
(140,000)
-
Payments for purchases of property, equipment and branches construction
(3,193,660)
(366,618)
Proceeds from selling property and equipment
6,006
-
Proceeds from redemption of financial assets at amortized cost
2,537,401
285,507
Payments for purchases of financial assets at amortized cost
(23,457,385)
(53,240,480)
Payments for purchases of financial assets at fair value through OCI
(29,004,342)
(26,284,875)
Proceeds from selling financial assets at fair value through OCI
6,057,967
26,380,625
Net cash generated from (used in) investing activities
(46,967,315)
(53,221,059)
Mar. 31, 2025
Mar. 31, 2024
Cash flow from financing activities
Other loans
(13,765)
6,700,881
Dividends paid
(14,160,152)
(5,078,792)
Issued debt instruments
(22,830)
1,626,167
Net cash generated from (used in) financing activities
(14,196,747)
3,248,256
Net (decrease) increase in cash and cash equivalent during the period
98,506,291
67,547,214
Beginning balance of cash and cash equivalent
227,028,744
233,912,193
Cash and cash equivalent at the end of the period
325,535,035
301,459,407
Cash and cash equivalent comprise:
Cash and balances at the central bank
9
67,709,656
36,542,863
Due from banks
314,289,639
291,980,200
Treasury bills and other governmental notes
11
115,964,828
119,754,167
Obligatory reserve balance with CBE
(43,718,398)
(19,383,018)
Due from banks with maturity more than three months
(14,867,792)
(7,554,480)
Treasury bills and other governmental notes with maturity more than three months
(113,842,898)
(119,880,325)
Total cash and cash equivalent
325,535,035
301,459,407
Condensed Separate Interim statement of changes in shareholders' equity
Issued and paid capital
Legal reserve
General reserve
General risk reserve
Capital reserve
Reserve for financial assets at fair value through OCI
Banking risks reserve
Retained earnings
Reserve for employee stock ownership plan
Total
Mar. 31, 2024
Beginning Balance at 1 January 2024
30,195,010
4,770,354
39,840,707
1,549,445
21,155
(16,808,265)
15,230
29,230,360
1,486,010
90,300,006
Transferred to reserves
-
1,438,320
21,958,960
-
1,663
-
-
(23,398,943)
-
-
Dividend paid
-
-
-
-
-
-
-
(5,366,429)
-
(5,366,429)
Net profit for the period
-
-
-
-
-
-
-
11,946,597
-
11,946,597
Net change on financial assets at fair value through OCI after tax
-
-
-
-
-
1,977,715
-
-
-
1,977,715
Transferred (from) to banking risk reserve
-
-
-
-
-
-
2,694
(2,694)
-
-
Effect of ECL in fair value of debt instruments measured at fair value through OCI
-
-
-
-
-
745,406
-
-
-
745,406
Cost of employees stock ownership plan (ESOP)
-
-
-
-
-
-
-
-
300,000
300,000
Balance at 31 March 2024
30,195,010
6,208,674
61,799,667
1,549,445
22,818
(14,085,144)
17,924
12,408,891
1,786,010
99,903,295
Issued and paid capital
Legal reserve
General reserve
General risk reserve
Capital reserve
Reserve for financial assets at fair value through OCI
Banking risks reserve
Retained earnings
Reserve for employee stock ownership plan
Total
Mar. 31, 2025
Beginning Balance at 1 January 2025
30,431,580
6,208,674
62,422,792
1,549,445
22,818
(7,095,741)
17,924
56,260,451
1,868,235
151,686,178
Transferred to reserves
-
2,771,284
18,971,298
-
2,246
-
-
(21,744,828)
-
-
Dividends paid
-
-
-
-
-
-
-
(14,714,434)
-
(14,714,434)
Net profit for the period
-
-
-
-
-
-
-
16,595,612
-
16,595,612
Net change on financial assets at fair value through OCI after tax
-
-
-
-
-
2,141,325
-
-
-
2,141,325
Transferred (from) to banking risk reserve
-
-
-
-
-
-
(2,628)
2,628
-
-
Effect of ECL in fair value of debt instruments measured at fair value through OCI
-
-
-
-
-
841,407
-
-
-
841,407
Cost of employees stock ownership plan (ESOP)
-
-
-
-
-
-
-
-
316,185
316,185
Balance at 31 March 2025
30,431,580
8,979,958
81,394,090
1,549,445
25,064
(4,113,009)
15,296
36,399,429
2,184,420
156,866,273




 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
QRFEXLBFEELBBBQ